Weiss Multi-Strategy Advisers LLC - RAPTOR PHARMACEUTICAL CORP ownership

RAPTOR PHARMACEUTICAL CORP's ticker is RPTP and the CUSIP is 75382F106. A total of 84 filers reported holding RAPTOR PHARMACEUTICAL CORP in Q4 2014. The put-call ratio across all filers is 2.59 and the average weighting 0.1%.

Quarter-by-quarter ownership
Weiss Multi-Strategy Advisers LLC ownership history of RAPTOR PHARMACEUTICAL CORP
ValueSharesWeighting
Q2 2015$158,000
-24.8%
10,000
-50.0%
0.01%
-14.3%
Q4 2014$210,000
+9.4%
20,0000.0%0.01%
+40.0%
Q3 2014$192,000
-11.9%
20,000
+5.8%
0.01%0.0%
Q2 2014$218,000
-41.1%
18,900
-48.9%
0.01%
-28.6%
Q1 2014$370,000
+105.6%
37,000
+168.3%
0.01%
+75.0%
Q4 2013$180,00013,7900.00%
Other shareholders
RAPTOR PHARMACEUTICAL CORP shareholders Q4 2014
NameSharesValueWeighting ↓
Parametrica Management Ltd 16,355$244,0003.04%
EAM Investors, LLC 175,761$2,626,0000.52%
Tekla Capital Management LLC 110,000$1,643,0000.18%
Jane Street Holding, LLC 447,456$6,676,0000.08%
A.R.T. Advisors, LLC 95,164$1,419,0000.08%
CREDIT SUISSE AG/ 5,079,886$75,792,0000.08%
NOMURA HOLDINGS INC 736,362$10,936,0000.07%
ADAGE CAPITAL PARTNERS GP, L.L.C. 1,000,000$14,920,0000.04%
ROYAL BANK OF CANADA 2,971,616$44,337,0000.03%
LORD, ABBETT & CO. LLC 721,849$10,784,0000.02%
View complete list of RAPTOR PHARMACEUTICAL CORP shareholders